| Artes Medical Announces Completion Of Enrollment In 1,000 Patient Post-Marketing ArteFill Study (Dermal Filler) Artes Medical, Inc. (Nasdaq:ARTE), a medical aesthetics company, today announced that enrollment has been completed in the 1,000-patient post-marketing study required by the FDA. The study follows patients treated with ArteFill®, the first and only FDA-approved non-resorbable dermal filler, for a five-year period. medicalnewstoday.com |
New York Times Examines Reconstructive Surgery Options For Women With Breast Cancer The New York Times on Tuesday examined reconstructive breast surgery options provided to cancer patients undergoing mastectomies. According to the Times, despite recent advances in reconstructive breast surgery procedures, many plastic surgeons fail to inform women about the extent of their options. medicalnewstoday.com |
News From Plastic Surgery 2009 Botox Takes a Shot at Pain No longer just a wrinkle fighter, Botox® may have indications as a pain medication to fight Chronic Regional Pain Syndrome (CRPS), reports a new study presented at the American Society of Plastic Surgeons (ASPS) Plastic Surgery 2009 conference, Oct. 23-27, in Seattle. Between 5 and 26 people out of every 100,000 have their lives significantly disrupted by some form of chronic pain. medicalnewstoday.com |
'Botax' On Cosmetic Surgery Questioned The Associated Press: "The White House and Senate Democrats have turned to a proposal to tax breast implants, tummy tucks, wrinkle-smoothing injections and other procedures as they search for ways to pay for costly health care overhaul plans... mnt.to |
Normal Blood Glucose Levels In Diabetics Presenting For Surgery Were Associated With Increased Risk Of Mortality From Non-Cardiac Surgery A clinical study presented at ANESTHESIOLOGY 2010 discovered that diabetics who presented for non-cardiac surgery with near normal blood sugar levels were at increased risk of death, as compared with their non-diabetic counterparts... mnt.to |